Trans Medica (India) Profile
Key Indicators
- Authorised Capital ₹ 30.70 Cr
- Paid Up Capital ₹ 30.59 Cr
- Company Age 39 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 11.78 Cr
- Revenue Growth %
- Profit Growth 2791420.00%
- Ebitda
- Net Worth 100.00%
- Total Assets %
About Trans Medica (India)
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U25201TN1985PLC012380
- Company No.
012380
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
19 Nov 1985
- Date of AGM
30 Jun 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Trans Medica (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Krishnamachariar Seshadri | CFO | 10-Mar-2020 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mani  | Director | 16-Jun-2000 | Current |
| Tribhuvan Rathod | Director | 24-Jun-1997 | Current |
| Subramanian Santhanaraman | Director | 16-Jun-2000 | Current |
| Vidhya Srinivasan | Whole-Time Director | 27-May-2017 | Current |
Financial Performance of Trans Medica (India).
Trans Medica (India) Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 2791420% increase in profit. The company's net worth Soared by an impressive increase of 100%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Trans Medica (India)?
In 2020, Trans Medica (India) had a promoter holding of 81.55% and a public holding of 18.45%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Restile Ceramics LimitedMani is a mutual person
Denvik Technology Private LimitedSubramanian Santhanaraman is a mutual person
Bell Granito Ceramica LimitedMani is a mutual person
- Yuga Homes Limited
Mani is a mutual person
- V.V. Enterprises Private Limited
Subramanian Santhanaraman is a mutual person
Charges (Loans)
₹0
₹11.78 Cr
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 6.64 Cr
- Industrial Developmen Bank Of India : 5.14 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 May 1998 | Indian Overseas Bank | ₹9.40 M | Satisfied |
| 16 May 1998 | Indian Overseas Bank | ₹9.40 M | Satisfied |
| 27 Oct 1997 | Indian Overseas Bank | ₹2.39 Cr | Satisfied |
| 27 Feb 1995 | Indian Overseas Bank | ₹0.88 M | Satisfied |
| 16 Mar 1993 | Industrial Developmen Bank Of India | ₹3.75 Cr | Satisfied |
How Many Employees Work at Trans Medica (India)?
Unlock and access historical data on people associated with Trans Medica (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trans Medica (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trans Medica (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
